Retrophin, LLC Completes Reverse Merger With Desert Gateway, Inc.

Published: Dec 18, 2012

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc., a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases, today announced the successful completion of its merger with Desert Gateway, Inc. (OTCQB: RTRX) and its transition to a publicly-traded company. The combined company, currently trades as an over-the-counter (OTC) stock under the symbol RTRX.

Back to news